Long-term outcomes in patients with relapsed/refractory acute myeloid leukemia and other high-risk myeloid malignancies after undergoing sequential conditioning regimen based on IDA-FLAG and high-dose melphalan
Guijarro, F., Bataller, A., Diaz-Beyá, M., Garrido, A., Coll-Ferrà, C., Vives, S., . . . Esteve, J. (2022). Long-term outcomes … Read More
